Literature DB >> 27201958

The Randomized Blind Start Trial: Evaluation of A New Study Design for Assessing Clinical Outcomes in Rare and Heterogeneous Patient Populations.

J Signorovitch1, R Ayyagari2, E Kakkis3.   

Abstract

Entities:  

Year:  2014        PMID： 27201958     DOI： 10.1016/j.jval.2014.08.1963

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders.

Authors:  Andrew E Mulberg; Christina Bucci-Rechtweg; Joseph Giuliano; David Jacoby; Franklin K Johnson; Qing Liu; Deborah Marsden; Scott McGoohan; Robert Nelson; Nita Patel; Klaus Romero; Vikram Sinha; Sheela Sitaraman; John Spaltro; Vivian Kessler
Journal:  Orphanet J Rare Dis       Date:  2019-02-08       Impact factor: 4.123
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.